Skip to main content
logo
Latigo Biotherapeutics, Inc. (LTGO)
NASDAQ: LTGO · Real-Time Price · USD
20.06
+0.68 (3.51%)
At close: Aug 13, 2026, 4:00 PM EDT
20.01
-0.05 (-0.25%)
After-hours: Aug 13, 2026, 7:34 PM EDT

Latigo Biotherapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Mar '26 Dec '25 Dec '24
Cash & Equivalents
42.1869.4417.92
Cash & Short-Term Investments
42.1869.4417.92
Cash Growth
-287.53%-
Prepaid Expenses
2.72.183.25
Restricted Cash
0.190.19-
Other Current Assets
1.782.02-
Total Current Assets
46.8473.8321.16
Property, Plant & Equipment
0.91.071.41
Other Long-Term Assets
0.540.620.29
Total Assets
50.5875.5222.86

Liabilities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Mar '26 Dec '25 Dec '24
Accounts Payable
4.465.027.07
Accrued Expenses
9.5312.876.73
Current Portion of Leases
0.50.560.39
Other Current Liabilities
--0.25
Total Current Liabilities
14.4918.4514.44
Long-Term Leases
0.050.130.46
Other Long-Term Liabilities
0.040.040.04
Total Liabilities
14.5818.6114.93

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Mar '26 Dec '25 Dec '24
Additional Paid-In Capital
13.5111.464.37
Retained Earnings
-266.09-243.13-133.96
Total Common Equity
-252.58-231.67-129.6
Shareholders' Equity
3656.917.93
Total Liabilities & Equity
50.5875.5222.86

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Mar '26 Dec '25 Dec '24
Total Debt
0.550.690.85
Net Cash (Debt)
41.6268.7517.07
Net Cash Growth
-302.81%-
Net Cash Per Share
7.3912.673.91
Filing Date Shares Outstanding
5.945.644.36
Total Common Shares Outstanding
5.945.644.36
Working Capital
32.3555.386.73
Book Value Per Share
-42.49-41.05-29.71
Tangible Book Value
-252.58-231.67-129.6
Tangible Book Value Per Share
-42.49-41.05-29.71
Machinery
1.31.31.26
SEC Filings: 10-K · 10-Q